本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

6.33
+0.18002.93%
盤後6.400.0689+1.09%19:58 EDT
成交量:220.32萬
成交額:1,386.26萬
市值:6.75億
市盈率:-2.32
高:6.39
開:6.13
低:6.09
收:6.15
資料載入中...
2025/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities